Barriers to Heroin Injection Behaviour Change among Clients on Methadone Treatment: Experiences from Public Methadone Clinics in Dar es Salaam, Tanzania



Abstract Views
755

Downloads
550

Citations

Share

##plugins.themes.bootstrap3.article.sidebar##

Submitted Feb 4, 2022
Published Mar 11, 2022
10.24018/ejmed.2022.4.2.1236

Abstract viewed = 755 times

Table of Contents

##plugins.themes.bootstrap3.article.main##

Background: It is estimated that there are 50,000 injectable drug users in Tanzania. Tanzania is the first sub-Saharan African country to provide methadone treatment. This study explored barriers to heroin injection behavior change among clients on methadone treatment clinics in Dar es Salaam, Tanzania.

Methods: This was exploratory cross sectional study. Purposive sampling was used to select ten participants. In in-depth interview guide was used to collect data. Transcribed data were analyzed manually and subjected to thematic analysis.

Results: Various factors hinder heroin injecting behaviour change among methadone clients on methadone treatment. Specifically lack of perceived benefits of methadone treatment i hinder behaviour change of injecting heroin when one is enrolled on methadone treatment clinics. Additionally, social environment contributes to failure to change heroin injecting behaviour among clients on methadone treatment.

Conclusion: Different measures should be taken by methadone programs and stakeholders to overcome heroin injecting behaviour among clients on methadone.

Keywords: Heroin Injection, methadone, people who inject drugs Tanzania

Downloads

Download data is not yet available.

References

  1. Metzger DS, Zhang Y. Drug treatment as HIV prevention: Expanding treatment options. Current HIV/ AIDS Reports. 2010; 7(4): 220–225.
    DOI  |   Google Scholar
  2. Sullivan L, Metzger DS, Fudala PJ, Fiellin DA. Decreasing international HIV transmission: The role of expanding access to opioid agonist therapies for injection drug users. Addiction. 2005; 100: 150– 158.
    DOI  |   Google Scholar
  3. Ross MW, McCurdy SA, Kilonzo GP, Williams ML, Leshabari MT. Drug use careers and blood-borne pathogen risk behavior in male and female Tanzanian heroin injectors. Am J Trop Med Hyg. 2008; 79(3): 338-343.
    DOI  |   Google Scholar
  4. McCurdy SA, Williams ML, Kilonzo GP, Ross MW, Leshabari MT. Heroin and HIV risk in Dar es Salaam, Tanzania: youth hangouts, mageto and injecting practices. AIDS Care. 2005; 17(Suppl 1): S65–S76.
    DOI  |   Google Scholar
  5. UNODC. World Drug Report. 2016.
     Google Scholar
  6. McCurdy SA, Ross MW, Kilonzo GP, Leshabari MT, Williams ML. HIV/AIDS and injection drug use in the neighborhoods of Dar es Salaam, Tanzania. Drug and Alcohol Dependence. 2006; 82 (Suppl 1): S23–S27.
    DOI  |   Google Scholar
  7. TACAIDS Commission for AIDS (TACAIDS), Zanzibar AIDS Commission (ZAC), National Bureau of Statistics (NBS), Office of Chief Government Statistician Zanzibar (OCGSZ), & ICF International (ICF). Third Tanzania HIA/AIDS and malaria indicator survey 2011–2012. [Internet] 2013. Available from: http://dhsprogram.com/pubs/pdf/AIS11/AIS11.pdf.
     Google Scholar
  8. Niaura R. Cognitive Social Learning and related perspectives on drug craving. Addiction. 2000; 95 (Suppl. 2): 155– 63. [13]
    DOI  |   Google Scholar
  9. Witkiewitz K, Marlatt GA. Relapse prevention for alcohol and drug problems: That was Zen, this is Tao. American Psychologist. 2004; 59: 224-235.
    DOI  |   Google Scholar
  10. Connock M, Juarez-Garcia A, Jowett S, et al. Methadone and Buprenorphine for the management of opioid dependence: a systematic review and economic evaluation. Health Technol Assess. 2007; 11: 13–28.
    DOI  |   Google Scholar
  11. Bruce RD. Methadone as HIV prevention: High volume methadone sites to decrease HIV incidence rates in resource limited settings. International Journal of Drug Policy. 2010; 21(2): 122–124.
     Google Scholar
  12. Ball JC, Ross A, Dole VP. The effectiveness of methadone maintenance treatment: Patients, programs, services and outcome. xiv. New York: Springer-Verlag. 1991.
     Google Scholar
  13. Mbatia J, Jenkins R, Singleton N, White B. Prevalence of alcohol consumption and hazardous drinking, tobacco and drug use in urban Tanzania, and their associated risk factors. Int. J. Environ. Res. Public Health. 2009; 6: 1991-2006.
    DOI  |   Google Scholar
  14. Maman S, Mbwambo JK, Hogan NM, Kilonzo GP, Sweat M. Women’s barriers to HIV-1 testing and disclosure: Challenges for HIV-1 voluntary counseling and testing. AIDS Care. 2001: 595–603.
    DOI  |   Google Scholar
  15. Tiberio J, Lauren YI, Ndayongeje J, Welty AMS, Ngonyani A, Mwankemwa S, et al. Context and characteristics of illicit drug use in coastal and interior Tanzania. International Journal of Drug Policy. 2018; 51: 20-26.
    DOI  |   Google Scholar
  16. Palamar JJ, Acosta P, Sharman S, Ompad DC, Cleland CM. Self-reported use of novel psychoactive substances among attendees of electronic dance music. Am J Drug Alcohol Abuse. 2016; 42(6): 624-632.
    DOI  |   Google Scholar
  17. Ratliff EA, McCurdy SA, Mbwambo JKK, Lambdin BH, Voets A, Pont S, et al. An Overview of HIV prevention interventions for people who inject drugs in Tanzania. Adv Prev Med. 2013: 183187.
    DOI  |   Google Scholar
  18. Wodak A, Maher L. The effectiveness of harm reduction in preventing HIV among injecting drug users. New South Wales Public Health Bulletin. 2010; 21: 69.
    DOI  |   Google Scholar
  19. Guise A, Kazatchkine M, Rhodes T, Strathdee SA. Editorial commentary: successful methadone delivery in East Africa and its global implications. Clin Infect Dis. 2014; 59(5): 743–4.
    DOI  |   Google Scholar
  20. Ng’wanakilala F. New treatment gives hope to East Africa’s drug users. Bull World Health Organ. 2013; 91(2): 89–90.
    DOI  |   Google Scholar
  21. Bruce RD. Methadone as HIV Prevention: High Volume Methadone Sites to Decrease HIV Incidence Rates in Resource Limited Settings. Int J Drug Policy. 2011; 21(2): 122–4.
    DOI  |   Google Scholar
  22. Lambdin BH, Masao F, Chang O, Kaduri P, Mbwambo J, Magimba A, et al. Methadone Treatment for HIV prevention-feasibility, retention, and predictors of attrition in Dar es Salaam, Tanzania: a retrospective cohort study. Clin Infect Dis. 2014; 59: 1–8.
    DOI  |   Google Scholar
  23. Luo X, Zhao P, Gong X, Zhang L, Tang W, Zou X. Concurrent heroin use and correlates among methadone maintenance treatment clients : a 12-month follow-up study in Guangdong. International Journal of Environmental Research and Public Health 2016; 13(3).
    DOI  |   Google Scholar
  24. Lin C, Wu Z, Detels R. Opiate users’ perceived barriers against attending methadone maintenance therapy: a qualitative study in China. Subst Use Misuse. 2011; 46(9): 1190–8.
    DOI  |   Google Scholar
  25. Masao FA. First International conference on drug policies in PRAIA. Comprehensive Interventions for Injection Drug Users : Tanzania Experiences on MAT & NSP Programs. 2013.
     Google Scholar
  26. Li L, Lin C, Wan D, Zhang L, Lai W. Concurrent heroin use among methadone maintenance clients in China. Addict Behav. 2012; 37(3): 264–8.
    DOI  |   Google Scholar
  27. Amato L, Davoli M, Perucci CA, Ferri M, Faggiano F, Mattick RP. An overview of systematic reviews of the effectiveness of opiate maintenance therapies: Available evidence to inform clinical practice and research. Journal of Substance Abuse Treatment. 2005; 28.
    DOI  |   Google Scholar
  28. Senbanjo R, Wolff K, Marshall EJ, Strang J. Persistence of heroin use despite methadone treatment: Poor coping self-efficacy predicts continued heroin use. Drug Alcohol Rev. 2009; 28: 608–15.
    DOI  |   Google Scholar
  29. Jamieson, Beals L. Literature Review: Methadone Maintenance Treatment; Office of Canada’s Drug Strategy, Health Canada. 2002.
     Google Scholar
  30. Day E, Best D, George S, Copello. Drug Users’ Experiences of Prescribed Injectable Methadone: The Impact on Drug Use and Perceptions of Stability. J Drug Issues. 2007; 37(2): 341–55.
    DOI  |   Google Scholar
  31. Tuten M, Jones HE. A partner’s drug-using status impacts women’s drug treatment outcome. Drug Alcohol Depend. 2003; 70(3): 327–30.
    DOI  |   Google Scholar
  32. Wasserman DA, Stewart AL, Delucchi KL. Social support and abstinence from opiates and cocaine during opioid maintenance treatment. Drug Alcohol Depend. 2001; 65(1): 65–75.
    DOI  |   Google Scholar
  33. De Leon G, Wexler HK. Heroin addiction: its relation to sexual behavior and sexual experience. J Abnorm Psychol. 1973; 81(1): 36–8.
    DOI  |   Google Scholar
  34. Yee A, Danaee M, Loh HS, Sulaiman AH, Ng CG. Sexual dysfunction in heroin dependents: A comparison between methadone and buprenorphine maintenance treatment. PLoS One. 2016; 11(1): 1–12.
    DOI  |   Google Scholar
  35. Jalal A. Sexual activity in relapse process among Iranian drug users. A qualitative study. Life Science Journal. 2013; 410–4.
     Google Scholar
  36. Vijay M, Kiran KP, Narendra JS, Sudarshan AB, Karunakara A, Santosh TS, et al. Substance Use and Sexual Dysfunction; Review Article. J Evol Med Dent Sci. 2013; 32(44): 8624.
     Google Scholar
  37. Hosseini SH, Isapour A, Tavakoli M, Taghipour M, Rasuli M. Erectile dysfunction in methadone maintenance patients: a cross sectional study in northern Iran. Iranian Journal of Psychiatry. 2013; 8(4): 172–178.
     Google Scholar
  38. Lions C, Carrieri MP, Michel L, Mora M, Marcellin F, Morel A, et al. Predictors of non-prescribed opioid use after one year of methadone treatment: An attributable-risk approach (ANRS-Methaville trial). Drug Alcohol Depend. 2014; 135(1): 1–8.
    DOI  |   Google Scholar
  39. The United Republic of Tanzania. Ministry of Health and Social Welfare. Medically Assisted Treatment for Opioid Dependence Commission. A Clinical Guide for Zonal and Regional Referral Hospitals. 2010. Dar es Salaam, Tanzania.
     Google Scholar
  40. Yusuph K, Negret I. Adolescents and Drug Abuse in Tanzania : History and Evolution. Advances in Research. 2016; 7(2): 1–10.
    DOI  |   Google Scholar